Applikon partners with Sotelab Brazil to strengthen LatAm distribution network
Press Release | Applikon Biotechnology B.V.
MARCH 20, 2020
Delft, The Netherlands: – Dutch-based upstream bioprocess equipment specialist Applikon Biotechnology B.V. (Applikon) has announced a partnership with one of Latin America’s leading suppliers and distributors of laboratory and life sciences equipment, Sotelab of Brazil.
The partnership between Applikon and Rio de Janeiro-based Sotelab Sociedade Técnica de Laboratório Ltda (Sotelab) significantly boosts South American market presence for Applikon’s advanced cultivation systems.
Laboratory sector leader
Sotelab is an important name in Brazil’s Medical Equipment & Supply Wholesale sector, with outlets in the major cities of Rio de Janeiro and São Paulo. It acts as agents for many leading laboratory equipment brands, supplying high technology equipment to life sciences companies, universities, research institutes, blood and industrial cell banks.
The distribution agreement allows Sotelab to act as distribution agents and offer technical and application support for the full range of Applikon products, including its innovative (single use) stirred tank bioreactors, advanced control systems and complete software solutions.
About Applikon Biotechnology
Netherlands-based Applikon Biotechnology B.V. (Applikon) is a manufacturer that specializes in upstream bioprocess equipment for the life sciences industries. Its mission is to provide reliable solutions for the bioprocess market to enable improved quality of life.
Applikon’s core business is in the development and supply of advanced bioreactor systems from laboratory scale, to pilot, to production scale, partnering with customers to implement scalable platforms from initial screening through development to full-scale production.
Applikon brings its ‘Engineering for Life’ mission to bear on solutions for a global client base that includes pharma and biotech companies, food industry, governmental and academic organizations.
Applikon designs, develops and assembles bioreactor systems, with all design and manufacturing conducted in-house. The Applikon portfolio covers key product and service areas including bioreactor cultivation systems, BioBundle turnkey systems, the unique BioSep Acoustic Perfusion System cell retention device, process control systems to automate bioprocesses and a range of proprietary AppliSens sensors, and automation (monitoring and data management) solutions.
Apart from its standard cultivation and turnkey systems, Applikon also offers Special Projects: custom solutions that focus on fulfilling strategic client needs such as long-term development, capability expansion and upscaling.
Applikon is headquartered at Delft in The Netherlands with subsidiaries in the UK, New Jersey and California, USA and a distributor network covering more than 35 countries.
In January 2020, Applikon became a fully owned subsidiary of Getinge AB, the Swedish-based leading global provider of products and systems contributing to quality enhancement and cost efficiency within healthcare and life sciences.
Further information: www.applikon-biotechnology.com
Sotelab Sociedade Técnica de Laboratório Ltda (Sotelab) is recognized across Brazil’s life sciences and laboratory research sectors for high quality services or its servicers and agile, efficient supply and delivery of high technology products.
Founded in 1993, Sotelab’s vision has always been to act as a differentiated company by providing end-to-end support, from the purchase to the installation and operation of the products supplied.
The company’s 58-strong workforce includes engineers, biologists, chemists and pharmacists.; all with extensive real-world experience and intensively trained by represented companies.
Sotelab places emphasis in continual investment in stock, equipment and spare parts, for prompt delivery.
The company is certified to ANVISA standard RDC 159 for Good Practices for Storage and Distribution of Health Products (GDP).
Further information at: https://www.sotelab.com.br/
Media Department, Applikon Biotechnology B.V.